Insider · CIK 0001555918

Gibson Neil W

Reports to the SEC for 4 companies · DALLAS, TX

sec.gov

Transactions

Companies

Filings

CIK

0001555918

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	TILInstil Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	0 sh	—	—	6,500
2026-05-29	STTKShattuck Labs, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+81K sh	—	—	81,000
2025-07-14	STTKShattuck Labs, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+33.2K sh	—	—	33,150
2025-05-28	TILInstil Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,500 sh	—	—	6,500
2024-06-21	STTKShattuck Labs, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+27.7K sh	—	—	27,700
2024-06-13	TILInstil Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2023-06-14	TILInstil Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,500 sh	—	—	1,500
2023-06-01	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,270 sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.8K sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,072 sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.1K sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.1K sh	—	—	0
2023-06-01	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2023-05-26	STTKShattuck Labs, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40.3K sh	—	—	40,258
2022-06-08	STTKShattuck Labs, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40.3K sh	—	—	40,258
2022-05-20	TILInstil Bio, Inc. · Employee Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2021-12-09	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award	Director	AAward	+12.1K sh	—	—	12,100
2021-12-09	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award	Director	AAward	+16.8K sh	—	—	16,800
2021-06-19	STTKShattuck Labs, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,434 sh	—	—	3,434
2021-03-18	TILInstil Bio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+52K sh	—	—	52,000
2020-12-22	STTKShattuck Labs, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,286 sh	—	—	1,286
2020-12-10	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award	Director	AAward	+12.1K sh	—	—	12,100
2020-03-20	TCR2 THERAPEUTICS INC.S Sale	Director	SSale	−648 sh	$7.94	−$5,145.12	0
2020-03-19	TCR2 THERAPEUTICS INC.S Sale	Director	SSale	−3,140 sh	$7.41	−$23.3K	648
2020-03-18	TCR2 THERAPEUTICS INC.S Sale	Director	SSale	−3,120 sh	$6.83	−$21.3K	3,788
2020-03-17	TCR2 THERAPEUTICS INC.S Sale	Director	SSale	−3,009 sh	$6.49	−$19.5K	6,908
2020-03-16	TCR2 THERAPEUTICS INC.S Sale	Director	SSale	−17.7K sh	$6.60	−$117K	9,917
2020-03-13	TCR2 THERAPEUTICS INC.S Sale	Director	SSale	−52K sh	$6.52	−$339K	27,640
2019-12-19	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2019-11-15	TCR2 THERAPEUTICS INC.J Other	Director	JOther	−218K sh	—	—	79,640
2019-11-13	TCR2 THERAPEUTICS INC.J Other	Director	JOther	−196K sh	—	—	297,614
2019-11-07	TCR2 THERAPEUTICS INC.J Other	Director	JOther	−213K sh	—	—	493,791
2019-04-11	TCR2 THERAPEUTICS INC.Stock Option (Right to Buy)A Award	Director	AAward	+6,270 sh	—	—	6,270
2019-02-19	TCR2 THERAPEUTICS INC.Series B Preferred StockC Conversion	Director	CConversion	−4.38M sh	—	—	0
2019-02-19	TCR2 THERAPEUTICS INC.C Conversion	Director	CConversion	+706K sh	—	—	706,351
2015-01-28	Regulus Therapeutics Inc.S Sale	Chief Scientific Officer	SSale	−8,655 sh	$18.66	−$161K	0
2015-01-28	Regulus Therapeutics Inc.S Sale	Chief Scientific Officer	SSale	−71.3K sh	$17.98	−$1.28M	8,655
2014-12-02	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+90.4K sh	—	—	90,378
2014-11-28	Regulus Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,500 sh	—	—	111,500
2014-11-28	Regulus Therapeutics Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,500 sh	$1.74	+$4,350	82,500
2014-11-28	Regulus Therapeutics Inc.S Sale	Chief Scientific Officer	SSale	−1,000 sh	$18.80	−$18.8K	81,500
2014-11-28	Regulus Therapeutics Inc.S Sale	Chief Scientific Officer	SSale	−1,500 sh	$19.63	−$29.4K	80,000
2014-10-29	Regulus Therapeutics Inc.S Sale	Chief Scientific Officer	SSale	−1,100 sh	$18.68	−$20.5K	81,400
2014-10-29	Regulus Therapeutics Inc.S Sale	Chief Scientific Officer	SSale	−200 sh	$20.41	−$4,082	80,000
2014-10-29	Regulus Therapeutics Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,500 sh	$1.74	+$4,350	82,500
2014-10-29	Regulus Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,500 sh	—	—	114,000
2014-10-29	Regulus Therapeutics Inc.S Sale	Chief Scientific Officer	SSale	−1,200 sh	$19.67	−$23.6K	80,200
2014-10-22	Regulus Therapeutics Inc.S Sale	Chief Scientific Officer	SSale	−3,300 sh	$14.44	−$47.6K	80,000
2014-10-22	Regulus Therapeutics Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,300 sh	$1.74	+$5,742	83,300
2014-10-22	Regulus Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,300 sh	—	—	116,500

Recent filings

Accepted (ET)
Jun 124
Gibson Neil W0001555918-26-000002
SEC(opens sec.gov)
Jun 24
Gibson Neil W0001193125-26-254125
SEC(opens sec.gov)
Jul 164
Gibson Neil W0000950170-25-096273
SEC(opens sec.gov)
May 294
Gibson Neil W0001789769-25-000068
SEC(opens sec.gov)
Jun 214
Gibson Neil W0000950170-24-076391
SEC(opens sec.gov)
Jun 134
Gibson Neil W0001789769-24-000064
SEC(opens sec.gov)
Jan 104
Gibson Neil W0001789769-24-000008
SEC(opens sec.gov)
Jun 14
Gibson Neil W0001104659-23-067039
SEC(opens sec.gov)
May 314
Gibson Neil W0000950170-23-025373
SEC(opens sec.gov)
Dec 194
Gibson Neil W0000899243-22-039016
SEC(opens sec.gov)
Jun 104
Gibson Neil W0000899243-22-021922
SEC(opens sec.gov)
May 254
Gibson Neil W0001789769-22-000053
SEC(opens sec.gov)
Dec 104
Gibson Neil W0001209191-21-069025
SEC(opens sec.gov)
Jun 224
Gibson Neil W0000899243-21-025421
SEC(opens sec.gov)
Mar 224
Gibson Neil W0001209191-21-022473
SEC(opens sec.gov)

Companies

Address

C/O INSTIL BIO, INC. 3963 MAPLE AVENUE, SUITE 350

DALLAS, TX, 75219